−185 KRW
−14.25 B KRW
74.96 M KRW
80.19 M
About PHARMABCINE INC.
Sector
Industry
CEO
Ji-Hyeong Lee
Website
Headquarters
Daejeon
Founded
2008
ISIN
KR7208340000
FIGI
BBG00MFDW1F2
PharmAbcine Inc. engages in the development of human therapeutic monoclonal antibody (mAb) for the treatment of cancer and inflammatory diseases. It focuses primarily on the out-licensing of candidate therapeutics and clinical applications. The company develops TTAC0001, a human anti-angiogenic mAb against VEGFR-2(KDR); and dual specific antibody technologies, including DIG-body and PIG-body for therapeutic use. The company was founded by Jin-San Yoo and Sang-Hoon Lee in September 3, 2008 and is headquartered in Daejeon, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 208340 is 2,915 KRW — it has decreased by −8.91% in the past 24 hours. Watch PHARMABCINE INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange PHARMABCINE INC. stocks are traded under the ticker 208340.
208340 reached its all-time high on Mar 19, 2019 with the price of 33,100 KRW, and its all-time low was 900 KRW and was reached on Nov 20, 2023. View more price dynamics on 208340 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
208340 stock is 18.65% volatile and has beta coefficient of 7.33. Track PHARMABCINE INC. stock price on the chart and check out the list of the most volatile stocks — is PHARMABCINE INC. there?
Yes, you can track PHARMABCINE INC. financials in yearly and quarterly reports right on TradingView.
208340 net income for the last quarter is −1.70 B KRW, while the quarter before that showed −2.27 B KRW of net income which accounts for 25.24% change. Track more PHARMABCINE INC. financial stats to get the full picture.
No, 208340 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 28, 2024, the company has 32.00 employees. See our rating of the largest employees — is PHARMABCINE INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMABCINE INC. EBITDA is −7.23 B KRW, and current EBITDA margin is −14.77 K%. See more stats in PHARMABCINE INC. financial statements.
Like other stocks, 208340 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMABCINE INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMABCINE INC. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMABCINE INC. stock shows the sell signal. See more of PHARMABCINE INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.